Researchers at the Comprehensive Center for Pain & Addiction conducted tests on five terpenes, finding promising results in their pain-relief capabilities.
A study from the University of Arizona Health Sciences, published in the journal PAIN, discovered that terpenes from Cannabis sativa were as effective as morphine in alleviating chronic neuropathic pain. Additionally, combining these two analgesics improved pain relief without negative side effects.
Some prior studies have shown that the Cannabis sativa plant and its two primary cannabinoids, tetrahydrocannabinol, or THC, and cannabidiol, or CBD, can be effective in managing chronic pain; however, the effects are generally moderate and can come with unwanted psychoactive side effects. Terpenes, the compounds that give plants their aroma and taste, offer an alternative path to pain relief without adverse side effects.
"A question that we've been very interested in is could terpenes be used to manage chronic pain?" said lead researcher John Streicher, PhD, a member of the Comprehensive Center for Pain & Addiction and a professor of pharmacology at the College of Medicine – Tucson. "What we found is that terpenes are really good at relieving a specific type of chronic pain with side effects that are low and manageable."
John Streicher, PhD, is a member of the University of Arizona Health Sciences Comprehensive Center for Pain & Addiction and a professor of pharmacology at the College of Medicine – Tucson. Credit: Noelle Haro-Gomez, University of Arizona Health Sciences
Research on Terpenes
Terpenes are found in all plants, and most plants have two dominant terpene species. Cannabis is unique in that it contains up to 150 terpenes with multiple terpenes acting as the dominant species. Streicher and the research team tested five terpenes that are found in moderate to high levels in Cannabis: alpha-humulene, beta-caryophyllene, beta-pinene, geraniol, and linalool.
In a prior study, Streicher's team found that four of those terpenes mimicked the effects of cannabinoids, including a reduction in the sensation of pain, in animal models of acute pain. For this study, they used a mouse model of chemotherapy-induced neuropathic pain, a type of chronic pain that occurs when highly toxic chemotherapy medications cause nerve damage that results in pain.
Cannabis sativa is unique in that it contains up to 150 terpenes with multiple terpenes acting as the dominant species. Credit: Noelle Haro-Gomez, University of Arizona Health Sciences
The terpenes were tested individually and compared with morphine. The research team found that each terpene was successful in reducing the sensation of pain at levels near to or above the peak effect of morphine. When the terpenes were combined with morphine, the pain-relieving effects of all five terpene/morphine combinations were significantly increased.
"That was really striking to us, but just because something relieves pain doesn't necessarily mean it's going to be a good therapy," Streicher said.
Comparing Terpenes and Opioids
Opioids are often used to treat many types of pain, but they can come with a host of unwanted side effects. Opioids activate the brain's reward system, which is what can lead to addiction, and can cause tolerance, a condition that occurs when the body gets used to a medication and needs increasingly larger doses to have the same effect. Opioids also can cause respiratory depression, which can lead to death.
"We looked at other aspects of the terpenes, such as: Does this cause reward? Is this going to be addictive? Is it going to make you feel awful?" Streicher said. "What we found was yes, terpenes do relieve pain, and they also have a pretty good side effect profile."
None of the terpenes had reward liability, making them a low risk for addiction. Some of the terpenes also did not cause aversive behaviors, which suggests they could be effective therapeutics without producing distressing side effects.
Finally, researchers tested different routes of terpene administration: injection, oral dosing, and inhalation of vaporized pure terpenes. They found that when terpenes were given orally or inhaled, the effects were significantly reduced or absent.
"A lot of people vape or smoke terpenes as part of cannabis extracts that are available commercially in states where cannabis use is legal," Streicher said "We were surprised to find that the inhalation route didn't have an impact in this study, because there are a lot of at least anecdotal reports saying that you can get the effects of terpenes whether taken orally or inhaled. Part of the confounding factor is that terpenes smell quite nice and it's hard to disguise that aroma, so people could be kind of having the psychosomatic placebo-style effect."
Because this is the first paper to examine the side effects of terpenes, Streicher will be using its findings to inform the next stage of research – can terpenes block the reward potential of an opiate such as morphine while at the same time enhancing its pain-relief potential?
"This brings up the idea that you could have a combination therapy, an opioid with a high level of terpene, that could actually make the pain relief better while blocking the addiction potential of opioids," Streicher said. "That's what we are looking at now."
Reference: "Terpenes from Cannabis sativa induce antinociception in a mouse model of chronic neuropathic pain via activation of adenosine A2A receptors" by Abigail M. Schwarz, Attila A. Keresztes, Thai A. Bui, Ryan A. Hecksel, Adriana Peña, Brianna A. Lent, Zhan-Guo Gao, Martín A. Gamez-Rivera, Caleb A. Seekins, Kerry A. Chou, Taylor L. Appel, Kenneth A. Jacobson, Fahad A. Al-Obeidi and John M. Streicher, 2 May 2024, PAIN.
DOI: 10.1097/j.pain.0000000000003265
The study was funded by the National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases.
News
Inflammation May Awaken Dormant Cancer Cells Years After Treatment
The body’s response to inflammation may disturb cancer cells that have been lying silent for years, giving them an opportunity to grow again. Researchers at the Francis Crick Institute have found that gut inflammation [...]
Where do nanoparticles go once they enter the body?
New international best practice guidance, co-written at ANSTO, sets out how to measure where nanoparticles like titanium dioxide end up in the body and how long they remain. The guidance has been shared by [...]
Long-Acting HIV Shots Could Solve a Major Treatment Challenge for Young People
A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to keep the virus suppressed when they received [...]
WHO Factsheets – The top 10 causes of death
In 2023, the 10 leading causes of death accounted for 33 million deaths, or 54% of the total 61 million deaths worldwide. The top global causes of death, in order of total number of lives lost, [...]
Aging Cells May Be Hiding From the Immune System – Scientists Think They Know How
Your immune system is supposed to clear out damaged cells. Researchers may have found how some of them hide and linger as the body ages. Researchers led by Cedars-Sinai Health Sciences University have identified [...]
Your Voice May Reveal How Fast Your Brain Is Aging
Researchers have developed a machine-learning “speech clock” that estimates age from subtle patterns in how people speak and what they say. It is possible that people’s voices may contain certain signals of aging that [...]
Optogenetics Pioneers Win 2026 Nobel Prize in Physiology or Medicine
The 2026 Nobel Prize in Physiology or Medicine has been awarded to Peter Hegemann, Georg Nagel, and Karl Deisseroth for the development of optogenetics, a revolutionary technology that uses light to control individual neurons [...]
Molecular Manufacturing: The Future of Nanomedicine – From NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
What is ‘American Covid’ and how bad is it?
Cases of so-called ‘American Covid’ are on the rise in the UK. The strain is officially called XFG, or ‘Stratus’, and is the most common variant in North America, hence the name. It might soon [...]
Researcher at Russian plague laboratory dies of ‘unknown’ infection
Russian authorities have imposed "anti-epidemic measures" after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. The researcher, a 28-year-old female [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
A Surprising Brain Signal Could Explain Why Eating Less Protein Extends Lifespan
A new paper suggests that limiting protein intake triggers a coordinated response throughout the body that may help explain how protein restriction affects healthy aging. Animals respond to protein restriction, or reduced protein in [...]
Back and shoulder surgery is often worse than useless
Millions of operations should be scrapped SIX IN TEN Britons have surgery at some point. So do lots of Americans, at a cost of perhaps $500bn a year, a third of all spending on [...]
Cocaine plays with mind, hijacks brain circuit, drives increasingly rigid and repetitive behavior
Researchers have found that cocaine hijacks brain circuit, which to drive increasingly rigid and repetitive behavior. The brain circuit that normally participates in selecting natural mouth and face movements, but which becomes disproportionately engaged [...]
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
The brain cancer glioblastoma is one of the most aggressive and treatment-resistant cancers known to medicine, carrying a median survival of just 12-15 months, even with the best available care. Now, researchers at the [...]
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol [...]

















